LP299V® features in TRIBIOTIC PRO launch in Thailand, a multi-biotic dietary supplement from the BioActive+ brand.
Probi® has spent over 35 years investigating the safety and efficacy of our probiotic strains. We conduct state-of-the-art preclinical and clinical studies, to evaluate the health effects and underlying mechanisms of our probiotics. Our scientists, and research groups around the globe, have published more than 80 human clinical trials on the LP299V® strain alone, primarily in the fields of digestive health and iron absorption.
Other strains have proven to be effective in other areas, such as immune, mental, metabolic, oral and bone health.
← In the left hand panel we present a few of our key clinical studies in selected areas.
No studies found. Please contact us.
Because local laws and regulations related to the distribution, marketing and sale of ingredients and finished products vary, Probi disclaims any regulatory compliance, warranties, product guidance or instruction of any kind. This brochure is provided for business-to-business communication and educational purposes only without warranties of any kind. Users should seek legal and/or regulatory advice prior to the market introduction of any Probi strain and before use of any claims to ensure compliance and thereafter on an ongoing basis when required.
Our grounding in pure science and scientific inquiry shines through everything we do. We continuously pursue new insights that...
At Probi® we believe that there is always more to learn, about new strains as well as strains we have known for many years. We...
Probi helps brands bring science-backed biotic innovations to market through clinically documented microbiome solutions.